Artivion, Inc. (AORT)

US — Healthcare Sector

Peers: INSP ITGR PRCT BKD ADUS ARDT LQDA SSII LFST COGT

Automate Your Wheel Strategy on AORT

With Tiblio's Option Bot, you can configure your own wheel strategy including AORT - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

symbol AORT
Rev/Share 8.9481
Book/Share 9.2879
PB 5.0453
Debt/Equity 0.0198
CurrentRatio 3.9319
ROIC 0.0362

MktCap 2219833738.0
FreeCF/Share -0.0263
PFCF -1790.1885
PE -242.1331
Debt/Assets 0.0101
DivYield 0
ROE -0.0256

Rating C-
Score 1
Recommendation Strong Sell
P/E Score 1
DCF Score 1
P/B Score 2
D/E Score 3

Recent Analyst Ratings

Type	Ticker	Analyst Firm	Previous Rating	Current Rating	Previous Price Target	Current Price Target	Date
Downgrade	AORT	Ladenburg Thalmann	Buy	Neutral	--	$38.8	Aug. 13, 2025
Initiation	AORT	Canaccord Genuity	--	Buy	--	$35	June 17, 2025
Initiation	AORT	JMP Securities	--	Mkt Outperform	--	$33	Oct. 23, 2024

News

Artivion, Inc. (AORT) Q2 2025 Earnings Call Transcript

AORT
Published: August 08, 2025 by: Seeking Alpha
Sentiment: Neutral

Artivion, Inc. (NYSE:AORT ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Lance A. Berry - Executive VP of Finance & CFO Pat MacKin - Corporate Participant Conference Call Participants Daniel Walker Stauder - Citizens JMP Securities, LLC, Research Division Destiny Alexandra Hance Buch - Ladenburg Thalmann & Co. Inc., Research Division John Glenn McAulay - Stifel, Nicolaus & Company, Incorporated, Research Division William John Plovanic - Canaccord Genuity Corp., Research Division Dorothy Morgan - Gilmartin Group LLC Operator Good day, ladies and gentlemen, and welcome to the Artivion Second Quarter 2025 Earnings Call.

image for news Artivion, Inc. (AORT) Q2 2025 Earnings Call Transcript

DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Artivion, Inc. Customers Whose Data May Have Been Compromised

AORT
Published: July 13, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEWTOWN, Pa., July 13, 2025 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating data privacy claims regarding an incident at Artivion, Inc. (“Artivion”).

image for news DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Artivion, Inc. Customers Whose Data May Have Been Compromised

Artivion, Inc. (AORT) Q1 2025 Earnings Call Transcript

AORT
Published: May 05, 2025 by: Seeking Alpha
Sentiment: Neutral

Artivion, Inc. (NYSE:AORT ) Q1 2025 Earnings Conference Call May 5, 2025 4:30 PM ET Company Participants Dorothy Morgan - Gilmartin Group LLC Pat Mackin - Chief Executive Officer Lance Berry - Chief Financial Officer Conference Call Participants John McAulay - Stifel Frank Takkinen - Lake Street Capital Markets Suraj Kalia - Oppenheimer & Company Mike Matson - Needham & Company Daniel Stauter - Citizens Jeffrey Cohen - Ladenburg Thalmann Operator Greetings. Welcome to Artivion's First Quarter 2025 Financial Conference Call.

image for news Artivion, Inc. (AORT) Q1 2025 Earnings Call Transcript

Artivion, Inc. (AORT) Q4 2024 Earnings Call Transcript

AORT
Published: February 24, 2025 by: Seeking Alpha
Sentiment: Neutral

Artivion, Inc. (NYSE:AORT ) Q4 2024 Earnings Conference Call February 24, 2025 4:30 PM ET Company Participants Dorothy Morgan - Gilmartin Group LLC Pat Mackin - Chief Executive Officer Lance Berry - Chief Financial Officer Conference Call Participants Rick Wise - Stifel Frank Takkinen - Lake Street Capital Markets Suraj Kalia - Oppenheimer & Company Mike Matson - Needham & Company Daniel Stauter - Citizens Jeffrey Cohen - Ladenburg Thalmann Operator Greetings, and welcome to the Artivion Fourth Quarter and Year End 2024 Financial Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.

image for news Artivion, Inc. (AORT) Q4 2024 Earnings Call Transcript

About Artivion, Inc. (AORT)

IPO Date 1993-02-12
Website https://artivion.com
Industry Medical - Devices
CEO James Patrick Mackin
Employees 1600

Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita Open Plus and E-vita Open Neo. It also provides E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion Inc. in January 2022. The company was founded in 1984 and is headquartered in Kennesaw, Georgia.